Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Monthly Ibandronate Persistence in Postmenopausal Osteoporosis
NCT00092053Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Dec 2004
- Primary completion
- Jul 2005
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of ibandronate in postmenopausal osteoporosis, sponsored by Organon & Co.. Started Dec 2004; status: completed.
02
Drugs
ibandronate
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on NCT00092053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00092053.